UiPath Inc. (PATH)

UiPath (PATH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Despite a 20% stock decline, we maintain a bullish view on UiPath due to its strategic pivot to Agentic AI and strong customer retention. PATH leads the growing RPA market, with robust demand and a co...

Both APP and PATH are technology companies leveraging artificial intelligence to enhance their platforms. Which one is a better investment?

NEW YORK & LAS VEGAS--(BUSINESS WIRE)--UiPath announced the launch of its generative AI-based UiPath Medical Record Summarization agent, powered by Google Cloud Vertex AI and Gemini models.

Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

UiPath's stock has dropped ~20% since January, presenting a buying opportunity for long-term investors, despite macroeconomic concerns and disappointing Q4 results. UiPath focuses on agentic automatio...

Five high-quality AI stocks are currently available on the dip at attractive valuations. These are ANET, PATH, JBL, BWXT and FIVN.

Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

UiPath, Zoom Communication, NVIDIA and Microsoft are leading the charge in transforming industries with agentic AI advancements in 2025.

With PATH stock having corrected significantly, we assess its current status to decide on the best strategy for the future.